Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1Phase 1 1

Status

Completed 66Terminated 15Recruiting 4Active not recruiting 4Not yet recruiting 3Withdrawn 2Unknown 2No longer available 1

Sponsor Class

OTHER 15INDUSTRY 4NIH 2OTHER_GOV 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Sarcoma 2Other hematologic neoplasm 2Myeloid 2Gastrointestinal 2

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Gastrointestinal Stromal Tumors 2Neoplasms 1Myeloproliferative Disorders 1Leukemia 1Hematologic Neoplasms 1Digestive System Neoplasms 1Blast Crisis 1

Interventions

pembrolizumab 241Carboplatin 167Injections 138Paclitaxel 119Gemcitabine 116Bevacizumab 112Cisplatin 105Docetaxel 82Cyclophosphamide 78Pemetrexed 76Capecitabine 69Fluorouracil 67Oxaliplatin 65Fulvestrant 57fludarabine 55Nivolumab 55Leucovorin 52Cetuximab 52130-nm albumin-bound paclitaxel 47Dexamethasone 46Rituximab 41atezolizumab 37venetoclax 35Drug Therapy 35toripalimab 34enzalutamide 34Irinotecan 34durvalumab 32Prednisone 32Letrozole 32

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × INDUSTRY × Imatinib Mesylate × Clear all
NCT07406633 2026-05-19

KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting

Kumquat Biosciences Inc.

Phase 2 Recruiting
46 enrolled
GastrointestinalSarcoma

Digestive System Neoplasms, Gastrointestinal Stromal Tumors

NCT04877522 2026-05-11

Asciminib Roll-over Study

Novartis

Phase 4 Recruiting
347 enrolled
MyeloidOther hematologic neoplasm

Blast Crisis, Myeloproliferative Disorders, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT06655246 2026-02-05

A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)

Kura Oncology, Inc.

Phase 1 Recruiting
157 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT05282108 2025-03-26

CARCML

Hikma Pharmaceuticals LLC

Recruiting
240 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Neoplasms, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡